LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
H3 Biomedicine Inc.
Headquarters:
Cambridge, MA, United States
Website:
N/A
Year Founded:
2011
Status:
Out of Business
BioCentury
|
Jan 5, 2023
Management Tracks
Sanofi’s Sarchi heads to Replimune
Plus: Albers joins Atlas, new CBO at Altimmune and updates from Nuvig, Zymeworks, Fulcrum, Step, Charm, Kymera and more
Read More
BioCentury
|
May 18, 2022
Management Tracks
Fromen to leave PacBio as CCO
Plus Vraniak joins Inversago as CFO and updates from Thabor, Glympse, Civetta and more
Read More
BioCentury
|
Jan 19, 2022
Management Tracks
Interim no more: Zhang assumes Overland’s CEO post; Maraganore, Ho join as advisers
Plus: Merck KGaA strategy, R&D execs; and updates from CureVac, Exo, Krystal and more
Read More
BioCentury
|
Nov 22, 2021
Management Tracks
Mallik resigns as CEO from Rafael
Plus: Connect, Fog, Elucida and Advanz
Read More
BioCentury
|
Feb 22, 2020
Management Tracks
Everest names new CEO; plus Merck, Gilead, Turning Point, Adaptimmune, AskBio and more
Read More
BioCentury
|
Nov 12, 2019
Company News
Skyhawk’s $80M Celgene deal expands remit to autoimmune
Read More
BioCentury
|
Nov 2, 2019
Company News
Management tracks: Genmab, Kintai, Aerie, Oasmia, Sangamo, Ovid, Checkmate, Third Pole, Actimed, IMV, Entasis, Rafael, Evaxion and Arvelle
Read More
BioCentury
|
Jan 23, 2019
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Dec 21, 2018
Company News
BMS, H3 Biomedicine evaluate RNA splicing technology
Read More
BioCentury
|
Jun 13, 2018
Company News
Management tracks: Salk Institute, Galectin
Read More
Items per page:
10
1 - 10 of 33